The FDA Warns Abbott Over Libre CGM Accuracy Concerns
Following a 2025 recall of millions of sensors, the FDA points to gaps in Abbott’s quality verification process, sparking renewed discussion on device reliability.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
How to Optimize Basal Insulin Settings for More Stable Glucose
I sat down with CDCES Gary Scheiner to discuss why basal insulin matters, how to know when it's off, and what stable basal looks like for insulin pumps and MDI.
